A phase I study of MEK162 and FOLFOX in chemotherapy-resistant metastatic colorectal cancer.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4244844716
